Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bioniche Pharma, a developer and manufacturer of injectable pharmaceuticals, has received the FDA approval for its 10mg/ml strength of ketamine hydrochloride injection, USP, the generic equivalent of JHP Pharmaceuticals's KetalarCIII.
Subscribe to our email newsletter
The 10mg/ml strength joins Bioniche’s current offering of Ketamine in 50mg/ml and 100mg/ml strengths and completes its full product line offering. Bioniche plans to launch the 10mg/ml strength in October 2008.
Steve Thornton, CEO of Bioniche Pharma, said: “We are pleased to offer our customers a full line of ketamine for their treatment needs.”